| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 12:18 | Vertical Aerospace Achieves Historic Piloted Thrustborne Transition | 446 | Business Wire |
Industry first under strict oversight of the UK Civil Aviation Authority (CAA), which is working in close collaboration with the European Union Aviation Safety Agency (EASA) toward certification... ► Artikel lesen | |
| 07:10 | Eli Lilly-Aktie verliert -23% - Trendbruch oder gesunde Korrektur? | 414 | sharedeals.de | Nachdem der Kurs der Eli Lilly-Aktie in den vergangenen Wochen deutlich unter Druck geraten ist und rund -23% vom Hoch verloren hat, zeigt sich eine spürbare Abschwächung im zuvor starken Aufwärtstrend.... ► Artikel lesen | |
| 16:10 | Assembly Biosciences und der 40-Milliarden-Dollar-Markt - Übernahme-Rallye voraus? | 353 | sharedeals.de | Die Aktie von Assembly Biosciences gehört derzeit zu den auffälligsten Diskrepanzen zwischen wissenschaftlichem Potenzial und Börsenbewertung im Biotechnologiesektor. Während das Unternehmen an neuartigen... ► Artikel lesen | |
| 12:02 | Simply Solventless Concentrates Ltd.: Simply Solventless Provides Restructuring Update, Including Expected Timing, and Announces Management Change | 299 | Newsfile | Not for distribution to U.S. news wire services or for dissemination in the United States.Calgary, Alberta--(Newsfile Corp. - April 6, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC")... ► Artikel lesen | |
| 12:02 | Amphastar Pharmaceuticals, Inc.: Amphastar Pharmaceuticals to Present at the 25th Annual Needham Healthcare Conference | 272 | ACCESS Newswire | RANCHO CUCAMONGA, CA / ACCESS Newswire / April 6, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") announced today that Bill Peters, CFO, Tony Marrs, EVP of Regulatory... ► Artikel lesen | |
| 13:06 | NRx Pharmaceuticals, Inc.: NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Labeling Alignment for NRx's Preservative-Free Ketamine Application | 244 | GlobeNewswire (Europe) | NRx has received a letter from the FDA Office of Generic Drugs indicating preliminary alignment on labeling for NRx's preservative-free ketamine product. Labeling remains subject to final supervisory... ► Artikel lesen | |
| 13:00 | Innocan Pharma Corporation: Innocan Pharma Announces Closing of Additional Debenture | 241 | PR Newswire | The Debenture will bear interest at the rate of 10% per annum and matures at the earlier of: (i) 12 months from the date of issuance; and (ii) the completion of the Company's previously announced proposed... ► Artikel lesen | |
| 13:06 | Opus Genetics, Inc.: Opus Genetics Solidifies Leadership Position in Gene Therapy Development for Inherited Retinal Diseases with Strategic Long-Term Financing by Oberland Capital | 235 | GlobeNewswire (Europe) | - Agreement includes up to $155 million in non-dilutive funding with an upfront payment of $35 million and a $5 million equity investment -- Strategic financing to accelerate development of earlier-stage... ► Artikel lesen | |
| 14:38 | Sunshine Biopharma Inc.: Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year | 214 | ACCESS Newswire | FORT LAUDERDALE, FL / ACCESS Newswire / April 6, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) ("Sunshine Biopharma" or the "Company"), a pharmaceutical company offering and developing life-saving medicines... ► Artikel lesen |
| Unternehmen / Aktien | Kurs | Dividende 12M | Div.-Rendite | Erw. Dividende | Erw. Ex.-Datum | |
|---|---|---|---|---|---|---|
| PERRIGO | 9,492 | 0,98 | +10,32 % | 0,29 | 02.03.2026 | |
| NOVO NORDISK | 31,930 | 1,57 | +4,92 % | 7,95 | 27.03.2026 | |
| SANOFI | 83,32 | 3,92 | +4,70 % | 4,12 | 05.05.2026 | |
| SINOPHARM | 2,302 | 0,08 | +3,48 % | 0,78 | 23.06.2026 | |
| ABBVIE | 180,60 | 5,85 | +3,24 % | 1,73 | 15.04.2026 | |
| GSK | 24,550 | 0,76 | +3,10 % | 0,18 | 19.02.2026 | |
| NOVARTIS | 133,58 | 4,11 | +3,08 % | 3,70 | 10.03.2026 | |
| ROCHE HOLDING | 361,00 | 10,85 | +3,01 % | 9,80 | 12.03.2026 | |
| CHUGAI PHARMACEUTICAL | 50,38 | 1,48 | +2,94 % | 66,00 | 29.06.2026 | |
| CSPC PHARMA | 1,068 | 0,03 | +2,81 % | 0,15 | 24.06.2026 |